Unlike global mortality rates of over 95% for Primary Amoebic Meningoencephalitis (PAM), Kerala has improved survival to 24% by using early diagnosis, rigorous supportive care, and the drug miltefosine as part of its treatment protocol.
Unbiased. Unfiltered. Unstoppable
Unlike global mortality rates of over 95% for Primary Amoebic Meningoencephalitis (PAM), Kerala has improved survival to 24% by using early diagnosis, rigorous supportive care, and the drug miltefosine as part of its treatment protocol.